TY - JOUR
T1 - DASH diet and change in serum uric acid over time
AU - Tang, Olive
AU - Miller, Edgar R.
AU - Gelber, Allan C.
AU - Choi, Hyon K.
AU - Appel, Lawrence J.
AU - Juraschek, Stephen P.
N1 - Funding Information:
Supported by cooperative agreements and grants from the National Heart, Lung, and Blood Institute (U01-HL57173, to Brigham and Women’s Hospital; U01-HL57114, to Duke University; U01-HL57190, to Pennington Biomedical Research Institute; U01-HL57139 and K08 HL03857-01, to Johns Hopkins University; and U01-HL57156, to Kaiser Permanente Center for Health Research) and by the General Clinical Research Center Program of the National Center for Research Resources (M01-RR02635, to Brigham and Women’s Hospital, and M01-RR00722, to Johns Hopkins University). NIAMS R01-AR065944, to Massachusetts General Hospital.
Funding Information:
OT is supported by the NIH Medical Scientist Training Program Grant 5T32GM007309. SPJ is supported by a NIH/NIDDK T32DK007732-20 Renal Disease Epidemiology Training Grant.
Publisher Copyright:
© 2017, International League of Associations for Rheumatology (ILAR).
PY - 2017/6/1
Y1 - 2017/6/1
N2 - The Dietary Approaches to Stop Hypertension (DASH) diet lowers serum uric acid (SUA) levels compared to the typical American (control) diet. However, the time required for the DASH diet to take effect is unknown. We analyzed data from a parallel arm, randomized-controlled trial in pre-hypertensive or hypertensive adults (N = 103), comparing the effects of DASH or a control diet on SUA measured at 30, 60, and 90 days. Effects were examined overall and within stratified subgroups based on baseline SUA status (SUA ≥6 mg/dL vs <6 mg/dL). The mean age of participants was 51.5 ± 9.7 years, 55% were women, 75% were black, 42% were obese, and 34% had hypertension. Twenty-four of the 103 (23%) participants had a baseline SUA ≥6 mg/dL. Overall, compared to the control, DASH lowered SUA by 0.5 mg/dL at 30 and 90 days. Among participants with baseline SUA ≥6 mg/dL, DASH lowered SUA by 0.8 and 1.0 mg/dL at 30 and 90 days, respectively. These findings demonstrate that the DASH diet reduces SUA within 30 days, with a sustained effect at 90 days, which is informative for healthcare providers counseling patients on time course expectations for uric acid reduction in response to dietary modification.
AB - The Dietary Approaches to Stop Hypertension (DASH) diet lowers serum uric acid (SUA) levels compared to the typical American (control) diet. However, the time required for the DASH diet to take effect is unknown. We analyzed data from a parallel arm, randomized-controlled trial in pre-hypertensive or hypertensive adults (N = 103), comparing the effects of DASH or a control diet on SUA measured at 30, 60, and 90 days. Effects were examined overall and within stratified subgroups based on baseline SUA status (SUA ≥6 mg/dL vs <6 mg/dL). The mean age of participants was 51.5 ± 9.7 years, 55% were women, 75% were black, 42% were obese, and 34% had hypertension. Twenty-four of the 103 (23%) participants had a baseline SUA ≥6 mg/dL. Overall, compared to the control, DASH lowered SUA by 0.5 mg/dL at 30 and 90 days. Among participants with baseline SUA ≥6 mg/dL, DASH lowered SUA by 0.8 and 1.0 mg/dL at 30 and 90 days, respectively. These findings demonstrate that the DASH diet reduces SUA within 30 days, with a sustained effect at 90 days, which is informative for healthcare providers counseling patients on time course expectations for uric acid reduction in response to dietary modification.
KW - DASH
KW - Diet
KW - Gout
KW - Trial
KW - Uric acid
UR - http://www.scopus.com/inward/record.url?scp=85016563483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85016563483&partnerID=8YFLogxK
U2 - 10.1007/s10067-017-3613-x
DO - 10.1007/s10067-017-3613-x
M3 - Article
C2 - 28361235
AN - SCOPUS:85016563483
SN - 0770-3198
VL - 36
SP - 1413
EP - 1417
JO - Clinical Rheumatology
JF - Clinical Rheumatology
IS - 6
ER -